Global Hematology Analyzers and Reagents Market Report and Forecast 2024-2032

Global Hematology Analyzers and Reagents Market Outlook

The global hematology analyzers and reagents market size was valued at USD 7.31 billion in 2023, driven by the rising number of blood disorders across the globe. The market size is anticipated to grow at a CAGR of 6.0% during the forecast period of 2024-2032 to achieve a value of USD 12.36 billion by 2032.

Hematology Analyzers and Reagents: Introduction

Hematology analyzers are used to perform a test, called complete blood count, with accuracy. This test is the first basic test that a physician asks someone to know about their health history.

Global Hematology Analyzers and Reagents Market Analysis

The rising prevalence of anemia is primarily driving the growth of the market. According to WHO, anaemia affects 571 million women and 269 million young children worldwide. The increasing initiatives by organization such as WHO to improve the accessibility status of healthcare related to anemia is driving the hematology analyzers and reagents and market growth. For instance, WHO has launched a comprehensive framework on reducing anemia. WHO has asked countries to speed up the process to reduce anaemia prevalence in women by 2025.

The increasing technological advancements in the hematology analyzers is leading to increase in demand as it can easily increase the capabilities of the laboratory.  The integration of advanced technologies, such as artificial intelligence in hematology analyzers, is aiding the global hematology analyzers and reagents and market growth as it reduces the chances of information overload and confusion. The increasing focus of key players on developing new and improved technologically advanced hematology analyzers is also driving the market growth.

Moreover, the rising number of clinical trials and research studies to improve the efficacy of hematology analyzers and reagents is directly contributing to the growth of the market. With increasing focus of key players on development of new technologies, the launch of new products in the market is aiding the growth of the market.

Global Hematology Analyzers and Reagents Market Segmentations

Market Breakup by Product and Services

• Products 
  • Hematology Analyzers 
  • 5-Part and 6-Part Hematology Analyzers 
  • Point of Care Testing Hematology Analyzers 
  • Semi-Automated Hematology Analyzers 
  • Automated Cell Counters 
  • Flow Cytometers 
  • Others 
• Reagents and Consumables 
  • Hematology Reagents 
  • Consumables 
  • Controls and Calibrators 
  • Slide Stainer’s 
  • Others

Market Breakup by Technology 

• Automated Hematology Analyzers

• Flow Cytometry

• Specialized Hematology Analyzers

Market Breakup by Applications

• Anemia

• Blood Cancer 

• Hemorrhagic Conditions 

• Infection-Related Conditions 

• Immune System Related Conditions 

• Others

Market Breakup by End User

• Hospital Laboratories 

• Blood Banks 

• Commercial Service Providers

• Government Reference Laboratories 

• Research and Academic Institute 

• Others

Market Breakup by Region

• North America

• Europe 

• Asia Pacific 

• Latin America 

• Middle East and Africa

Global Hematology Analyzers and Reagents Market Overview

The increasing prevalence of blood related disorders, like anemia and leukemia, is primarily driving the market growth. According to leukemia and lymphoma society, nearly 59,610 people are predicted to be diagnosed with leukemia by the end of 2024. The rising incidence of blood disorders such as haemophilia and blood clots across the globe are also driving the market growth as the increase in these disorders is adding further value to the overall global hematology analyzers and reagents market share. The rise in hemorrhagic conditions causing excessive bleeding internally in body organs is also anticipated to aid the demand for hematology analyzers and reagents.

Other than the rising prevalence of these disorders, the rapid technological advancements are also likely to propel the growth of the market in the coming years. Governments and key players across the globe are investing funds and efforts to develop more advanced products, which would significantly contribute to the overall development of the market during the forecast period.

Hematology Analyzers and Reagents Market: Competitor Landscape

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:

• Abbott Laboratories 

• Sysmex Corporation 

• Siemens Healthineers 

• Beckman Coulter 

• Roche Diagnostics 

• HORIBA Medical 

• Nihon Kohden Corporation 

• Boule Diagnostics 

• Mindray Medical International Limited 

• Bio-Rad Laboratories 

• Ortho Clinical Diagnostics 

• Shenzhen Mindray Bio-Medical Electronics Co., Ltd. 

• Diatron 

• EKF Diagnostics 

• Drew Scientific Inc.

Key Highlights of the Report